Access your free cancer and immunology resources ahead of the virtual summit
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
Dr. Raul Cano, Chief Scientific Officer at The BioCollective, discusses how to increase sequencing data accuracy and reproducibility and the future of the microbiome in healthcare
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
Dr. Chris Halbrook discusses how his team are exploring new methods to combat pancreatic cancer
Explore our exclusive interviews and free resources to help support your cancer research, diagnostics, and therapy development
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
Explore topics from immunoassays and immunotherapeutics to high-sensitivity troponin assays, metabolomics, and in situ hybridization
Explore topics including multiplexed assays, high-sensitivity troponin, 3D high-resolution X-ray microscopy, CRISPR, and Optimer reagents
Phoebe Koh Kang Sheing explains why collaboration with other labs is vital for research and how product reviews help
Watch this on-demand webinar to understand sample requirements and basic optimization steps for single-cell assays
The new cooperation aims to use BIORON's molecular biological tools and GENAPYS unique sequencing technology
Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
Subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations
Explore the advantages and applications of direct molecular testing for the diagnosis of bacterial and fungal pathogens
Explore topics from single-cell RNA sequencing sample preparation and precise weighing processes to COVID-19 serology testing and pediatric diagnostics
Watch this on-demand webinar to learn more about new updates of the NanoDrop One platform
From immunoassays and ELISAs to multi-mode microplate readers, discover the technologies making a difference for other scientists in your field
Trends in biomarker discovery methods and novel techniques advancing research, clinical diagnostics and therapeutic development
Dr. Chris Mason shares his extensive research into the SARS-CoV-2 immune response and the similarities experienced by astronauts landing back on Earth
The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus